Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

A History of the Science, Treatment of Rheumatologic Illnesses from Gold to Gene Therapy

  |  Issue: December 2017  |  

Finally, it is my distinct pleasure to welcome our great colleague, Phil Seo, MD, MHS, as your new physician editor. A talented educator, he serves as the Rheumatology Fellowship Program director at Johns Hopkins University School of Medicine in Baltimore. Phil is an exceptional clinical scholar with deep interests in vasculitis and other rheumatologic disorders. He has expertise in medical writing and editing, and I look forward to seeing his plans unfold in the coming issues of The Rheumatologist.

With that I bid you all a fond adieu!

References

  1. Arthur AB, Klinkhoff A, Teufel A. Nitritoid reactions: Case reports, review, and recommendations for management. J Rheumatol. 2001 Oct;28(10):2209–2212.
  2. Schmidt OEL. Chrysiasis. Arch Derm Syphilol. 1941;44(3):446–452.
  3. U2. Mysterious ways.
  4. Stecher RM. The American Rheumatology Association—Its origins, development and maturity. Arthritis Rheum. 1958;1(1):4–19.
  5. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009 Apr;9(4):271–285.
  6. Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017 Sep 21;377(12):1119–1131.
  7. National Institutes of Health. NIH launches trial to evaluate anti-inflammatory treatment for preventing heart attacks, strokes, and cardiovascular deaths [press release]. 2012 Aug 22.
  8. Watkin LB, Jessen B, Wiszniewski W, et al. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet. 2015 Jun;47(6):654–660.
  9. Beyond just promise, CRISPR is delivering in the lab today. The Conversation. 2017 May 17.
  10. Epstein SF, Wang ML. Bring back the mammoth. Harvard Crimson. 2017 Oct 19.
ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles

    Cardiovascular Risk in Tocilizumab Therapy for RA

    Observation and research have confirmed that patients with rheumatoid arthritis (RA) are at greater risk of cardiovascular disease than their peers of similar age and gender, and that traditional risk factors and chronic inflammation associated with RA apparently play a significant role in that risk. However, predicting which patients with rheumatoid arthritis are at greater…

    When Rheumatic Disease May Have Affected the Course of Western Civilization

    The study of rheumatology (and medicine) in art, history, literature and music is engaging and informative.1-12 In this article, we present some instances when rheumatic and autoimmune diseases in certain individuals may have affected the course of history in Western civilization. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEPhysicians are usually concerned, appropriately, with the effects of illness…